HB Fuller Co. (FUL) Misses Q1 EPS by 3c; Reaffirms FY11 EPS Outlook, Raises Sales Guidance
Tweet
Share
E-mailGet Alerts FUL Hot Sheet
Price: $60.15 -0.03%
Revenue Growth %: +6.4%
Financial Fact:
Cost of sales: -366.74M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Revenue Growth %: +6.4%
Financial Fact:
Cost of sales: -366.74M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
HB Fuller Co. (NYSE: FUL) reported Q1 EPS of $0.29, $0.03 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $339.55 million versus the consensus estimate of $341.85 million.
Reaffirms FY11 EPS outlook, boosts sales growth guidance from 8-10% to 10-12%.
Reaffirms FY11 EPS outlook, boosts sales growth guidance from 8-10% to 10-12%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- H.B. Fuller Announces AMS Shareholders Approve Proposed Acquisition
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
